While its highest numbers are in older adults, leukaemia is the most common type of cancer diagnosed in children and teenagers.
New research is desperately needed to treat the various types of leukaemias, prevent relapse and give hope to the children and adults battling this deadly cancer.
Leukaemia Support
Progressing research on a new drug and new drug target for IDH1-mutated leukaemia that specifically blocks cancer cell growth by blocking new lipid production.
Researcher
Associate Professor Daniel Thomas’ research aims to accelerate clinical trials and help many different cancer patients who relapse after current therapy.
Identifying the factors which drive acute myeloid leukaemia (AML) patients to relapse, to identify new targeted therapies to be used in combination with current clinically approved therapies to prevent disease relapse.
Researcher
Professor Stuart Pitson hopes his research will find clues to fight this aggressive, difficult-to-treat disease.
